Universal health coverage (UHC) is based on the principle that all individuals and communities should have equitable access to quality essential health services without suffering financial hardship. Many stakeholders are involved in making UHC a reality and the private sector is a key player in all countries, particularly in the area of service delivery.

Engaging the private sector should be a part of efforts to achieve UHC; governments and other stakeholders therefore need to engage with the private sector and identify common interests.

UHC2030 is a multi-stakeholder partnership to promote collaborative working in countries and globally on health systems strengthening in order to achieve UHC. Guided by the principles set out in the UHC2030 Global Compact for progress towards UHC, the partnership includes governments, international organizations, civil society organizations, the private sector, academia, and media.  

UHC2030 Private Sector Constituency

The UHC2030 Private Sector Constituency convenes private sector actors to foster dialogue and collaboration for UHC both within the constituency itself and with all UHC2030’s partners and health systems networks.

The World Economic Forum, the international organization for public-private cooperation, hosts the Private Sector Constituency of UHC2030.

The constituency has two levels of governance: 

  1. The Core Action Group determines the general directions and is responsible for the strategic management of the constituency. It comprises a minimum of six-member companies and two associations.
  2. The Consultative Group provides strategic input to the Core Action Group.

Read more about the governance structure

UHC2030 Global Multi-stakeholder Dialogue on Private Sector Engagement for UHC

UHC2030 is initiating a Global Multi-stakeholder Dialogue on Private Sector Engagement. We aim to bring all stakeholders together to identify areas where interests are aligned (or can be aligned), and to explore and foster new partnerships toward UHC outcomes including equitable access to quality essential health services and financial protection. For the purpose of this dialogue, we will focus on the for-profit private sector that directly provides services and goods for core health markets. This includes service providers, health insurers, manufacturers and distributors of medicines and health products and innovative and disruptive technologies with applications to the health market.

The Global Multi-stakeholder Dialogue on Private Sector Engagement will bring all stakeholders together to answer what role can and should the private sector play to reach UHC? More specifically, we are looking at options for aligning business objectives of the private sector to provide return on investment with public policy objectives of improved equitable access and financial protection.  

Country-level multi-stakeholder dialogues about private sector engagement for primary health care  (PHC)

UHC2030 will facilitate multi-stakeholder dialogues on how the private sector could engage for achieving the goal of UHC in pilot countries. The dialogues will enable governments to take a demand-driven approach to private sector engagement focused on PHC service delivery. The result will be that governments are better equipped to make decisions about the appropriate role of the private sector in meeting national health priorities. Through similar projects of partners, UHC2030 will disseminate lessons-learned from the processes on how to run public private dialogues for UHC.

Composition of the private sector constituency

UHC2030 is looking to work with for-profit private sector entities that directly provide services and goods within the health value chain, such as service providers, health insurers, and manufacturers and distributors of medicines and health products as well as innovative and disruptive technologies with applications to the health market.

Since November 2018, 30 private sector entities have joined the UHC2030 Private Sector Constituency, and a full list can be found below.

Current private sector constituency

Accessible Quality Health Services, South Africa

Allied World Asia, Singapore

Amref Enterprises Limited, Kenya

Apollo Hospital, India

Becton, Dickinson and Company, USA

Fullerton Healthcare Corporation Limited, Singapore

GE Medical Systems, France

German Healthcare Partnership, Germany

GlaxoSmithKline, UK

Global Diagnostic Imaging, Healthcare IT & Radiation Therapy Trade Association, Belgium

Global Self-Care Federation, Switzerland

Healthcare Federation of Nigeria, Nigeria

Henry Schein, USA

International Federation of Pharmaceutical Manufacturers and Associations, Switzerland

Japan Pharmaceutical Manufacturers Association, Japan

Johnson Johnson, Belgium

Kenya Association of Pharmaceutical Industry, Kenya

MEDx eHealthCenter, Netherlands

Merck, USA

Mission & Co, Malaysia

Novartis, Switzerland

Novo Nordisk, Denmark

Organization of Pharmaceutical Producers of India, India

Ottobock, Germany

Pfizer, USA

Pharmaceutical Society of Kenya, Kenya

Royal Philips, Netherlands

Sanofi, France

Sumitomo Chemical Company, Japan

Takeda Pharmaceutical Company, Japan

Private Sector News

16/07/2019

News from the private sector constituency with a new deadline for...

14/06/2019

An event to discuss how governments can engage with the private...

28/01/2019

Are you a private sector entity interested in joining our...

17/10/2018

UHC2030 and WHO’s country simulation exercise during the Health...

13/06/2018

A side event at the World Health Assembly 71, Geneva, Switzerland

 

“It is essential to reframe public and private sector engagement as a partnership for shared outcomes.”

Peter Salama, Executive Director UHC/Life Course at WHO

 

You are currently offline. Some pages or content may fail to load.